指南与共识头颈与中枢神经肿瘤

脑转移局部治疗临床试验设计:RANO-BM工作组指南

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.
指南 / 共识 · Lancet Oncol · 2018-01-01

本指南由RANO-BM工作组制定,针对实体瘤脑转移局部治疗的临床试验设计提出推荐。内容涵盖终点选择标准、早期与晚期试验的分析方法、肿瘤特异性终点与临床意义终点的关联,以及竞争风险下局部控制评估的问题,并据此给出具体设计建议。

要点

  • 早期试验侧重发现治疗信号,晚期试验侧重确认临床获益。
  • 终点选择需区分肿瘤特异性终点与临床意义终点。
  • 局部控制评估需考虑竞争风险的影响。

核心结论

  • 针对实体瘤脑转移局部治疗的临床试验设计,RANO-BM工作组就终点选择、分析方法和局部控制评估等提出推荐。

研究设计与样本

  • 本指南由Response Assessment in Neuro-Oncology Brain Metastases(RANO-BM)工作组制定,聚焦实体瘤中枢神经系统转移局部治疗的临床试验设计。

主要发现

  • 早期试验关注发现治疗信号以决定后续开发,晚期试验关注通过临床意义终点确认治疗影响。
  • 肿瘤特异性终点与临床意义终点之间存在关联,需在设计中予以考虑。
  • 局部控制的评估在竞争风险背景下可能存在需关注的问题。

关键数值与推荐

  • 指南讨论了终点选择标准,并针对早期和晚期试验分别讨论了适宜的分析方法。
  • 指南就局部治疗脑转移的临床试验设计提出了具体推荐。

临床怎么用

  • 肿瘤内科医生在解读或设计脑转移局部治疗试验时,应参考本指南的终点选择与分析推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The goals of therapeutic and biomarker development form the foundation of clinical trial design, and change considerably from early-phase to late-phase trials. From these goals, decisions on specific clinical trial design elements, such as endpoint selection and statistical approaches, are formed. Whereas early-phase trials might focus on finding a therapeutic signal to make decisions on further development, late-phase trials focus on the confirmation of therapeutic impact by considering clinically meaningful endpoints. In this guideline from the Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) working group, we highlight issues related to, and provide recommendations for, the design of clinical trials on local therapies for CNS metastases from solid tumours. We discuss endpoint selection criteria, the analysis appropriate for early-phase and late-phase trials, the association between tumour-specific and clinically meaningful endpoints, and possible issues related to the estimation of local control in the context of competing risks. In light of these discussions, we make specific recommendations on the clinical trial design of local therapies for brain metastases.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Alexander BM, Brown PD, Ahluwalia MS, et al. Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncol. 2018. PMID: 29304360. doi:10.1016/S1470-2045(17)30692-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。